HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

At Colgate Helm, Wallace Expected To Continue Cook's Strategies

Executive Summary

Noel Wallace, also named to board, says Colgate will continue to prioritize brand building, innovation in current product segments, expanding in channels and markets, maximizing e-commerce growth and investing to drive penetration in growing populations. He joined the oral, personal and home care product and pet nutrition company in 1987 and has served in senior management roles around the world.

You may also be interested in...



Colgate’s Prestige Skin-Care Acquisitions Inspire Interest In Similar Deals

Colgate-Palmolive plans to “dial up investments” in prestige skin-care brands EltaMD and PCA Skin, which helped drive North American sales up 3% in the first quarter, says CEO Noel Wallace during his first quarterly presentation as CEO.

Colgate Guidance Rides Price Increases, Earnings Outlook Dips On Higher Costs

Firm also estimates net revenues would be down 2% to $3.81bn due to losses to foreign exchange. Two-thirds of price increases coming in 2019 are either additional hikes for products the firm began in 2018 or planned in the relaunch of Colgate Total.

Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

Topics

Related Companies

UsernamePublicRestriction

Register

RS148578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel